Results from the XTEND-ed Clinical Trial Evaluating Efanesoctocog Alfa for the Treatment of Patients With Hemophilia A by Madaline Spencer| Published on: Feb 3, 2026

Results from the XTEND-ed Clinical Trial Evaluating Efanesoctocog Alfa for the Treatment of Patients With Hemophilia A by Madaline Spencer| Published on: Feb 3, 2026 Lynn Malec, MD, Versiti Blood Research Institute and Medical College of Wisconsin, discusses results from the XTEND-ed clinical trial evaluating efanesoctocog alfa for the treatment of patients with hemophilia A. https://checkrare.com/results-from-the-xtend-ed-clinical-trial-evaluating-efanesoctocog-alfa-for-the-treatment-of-patients-with-hemophilia-a/